EMCDDA trendspotter briefing: Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in east European Neighbourhood Policy countries


Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control measures by national governments. To investigate the effects of the pandemic on and the implications for drug markets, drug services and people who use drugs in the European Neighbourhood Policy (ENP) countries, the EMCDDA launched a trendspotter study. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug markets, drug services and people who use drugs in east ENP countries between March and May 2020.

A summary of the report is available in Azerbaijani, Armenian, Belarussian, Georgian, Ukrainian and Romanian (see below).


Download as PDF

Table of contents

  • Introduction
  • The trendspotter methodology
  • Presentation and interpretation of the results
  • References
  • Resources